STEREOTACTIC BODY VERSUS CONVENTIONAL FRACTIONATION EXTERNAL BEAM RADIOTHERAPY (EBRT) BOOST FOR HIGH-RISK PROSTATE CANCER (HR-PC); EARLY RESULTS OF PBS: A PHASE II RANDOMIZED TRIAL (NCT03380806)

被引：0

作者：

Gouveia, Andre ^{[1
]}

Mesci, Aruz ^{[2
]}

Isfahanian, Naghmeh ^{[1
]}

Dayes, Ian ^{[1
]}

Schnarr, Kara Lynne ^{[1
]}

Quan, Kimmen ^{[1
]}

Maharaj, Lindsay ^{[3
]}

Cuthbert, David ^{[4
]}

Hallock, Abhiram ^{[4
]}

Douvi, Georgia ^{[1
]}

Lukka, Himu ^{[1
]}

Goldberg, Mira ^{[1
]}

Wright, Jim ^{[1
]}

Swaminath, Anand ^{[1
]}

Chow, Tom ^{[5
]}

Diamond, Kevin ^{[4
]}

Ewusie, Joycelyne ^{[6
]}

Hajdok, George ^{[4
]}

Tsakiridis, Theodoros ^{[1
]}

机构：

[1] McMaster Univ, Hamilton, ON, Canada

[2] Princess Margaret Canc Ctr, Toronto, ON, Canada

[3] Hamilton Hlth Sci, Hamilton, ON, Canada

[4] Walker Family Canc Ctr, St Catharines, ON, Canada

[5] Juravinski Canc Ctr, Hamilton, ON, Canada

[6] St Josephs Hlth Care, Hamilton, ON, Canada

来源：

RADIOTHERAPY AND ONCOLOGY | 2024年 / 198卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S13 / S14

页数：2

共 34 条

[31] A PROSPECTIVE PHASE III RANDOMIZED TRIAL OF HYPOFRACTIONATION VERSUS CONVENTIONAL FRACTIONATION IN PATIENTS WITH HIGH-RISK PROSTATE CANCER: IN REGARD TO ARCANGELI C, ET AL. (INT J RADIAT ONCOL BIOL PHYS 2010;78:11-18)
Vogelius, Ivan R.
Bentzen, Soren M.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (01): : 316 - 316
[32] Results of a phase II trial of neoadjuvant abiraterone plus prednisone plus enzalutamide plus leuprolide (APEL) versus enzalutamide plus leuprolide (EL) for patients with high-risk localized prostate cancer (PC) undergoing radical prostatectomy (RP).
McKay, Rana R.
Xie, Wanling
Lis, Rosina
Ye, Huihui
Zhang, Zhenwei
Quoc-Dien Trinh
Chang, Steven Lee
Harshman, Lauren Christine
Ross, Ashley
Pienta, Kenneth J.
Lin, Daniel W.
Ellis, William J.
Montgomery, Robert B.
Chang, Peter
Wagner, Andrew
Bubley, Glenn
Kibel, Adam S.
Taplin, Mary-Ellen
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
[33] Results of a multicenter, randomized, phase 3 trial of trimodality therapy with I-125 brachytherapy, external beam radiation therapy, and long- versus short-term androgen deprivation therapy for localized high-risk prostate cancer (TRIP/TRIGU0907).
Yorozu, Atsunori
Namiki, Mikio
Saito, Shiro
Egawa, Shin
Yaegashi, Hiroshi
Hiroyuki, Konaka
Momma, Tetsuo
Fukagai, Takashi
Tanaka, Nobumichi
Ohashi, Toshio
Takahashi, Hiroyuki
Mizokami, Atsushi
Nakagawa, Yoko
Kikuchi, Takashi
Stone, Nelson
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
[34] Trimodality Therapy With Iodine-125 Brachytherapy, External Beam Radiation Therapy, and Short- or Long-Term Androgen Deprivation Therapy for High-Risk Localized Prostate Cancer: Results of a Multicenter, Randomized Phase 3 Trial (TRIP/TRIGU0907)
Yorozu, Atsunori
Namiki, Mikio
Saito, Shiro
Egawa, Shin
Yaegashi, Hiroshi
Konaka, Hiroyuki
Momma, Tetsuo
Fukagai, Takashi
Tanaka, Nobumichi
Ohashi, Toshio
Takahashi, Hiroyuki
Nakagawa, Yoko
Kikuchi, Takashi
Mizokami, Atsushi
Stone, Nelson N.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (02): : 390 - 401

← 1 2 3 4 →